Works matching IS 03407004 AND DT 2000 AND VI 49 AND IP 8

Results: 7

A bispecific single-chain antibody directed against EpCAM/CD3 in combination with the cytokines interferon α and interleukin-2 efficiently retargets T and CD3<sup>+</sup>CD56<sup>+</sup> natural-killer-like T lymphocytes to EpCAM-expressing tumor cells

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 8, p. 441, doi. 10.1007/s002620000130

By:

Flieger, Dimitri;
Kufer, Peter;
Beier, Imke;
Sauerbruch, Tilman;
Schmidt-Wolf, Ingo G. H.

Publication type:

Article

Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 8, p. 401, doi. 10.1007/s002620000134

By:

Uehara, Masataka;
Sano, Kazuo;
Wang, Zuo-Lin;
Sekine, Joji;
Ikeda, Hisazumi;
Inokuchi, Tsugio

Publication type:

Article

Comparative delineation of T cell clonotypes in coexisting syngeneic B16 melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 8, p. 426, doi. 10.1007/s002620000136

By:

Moerch, Ulrik;
Schrama, David;
Guldberg, Per;
Seremet, Tina;
Zeuthen, Jesper;
Becker, Jürgen C.;
thor Straten, Per

Publication type:

Article

Induction of human cytotoxic T lymphocytes that preferentially recognise tumour cells bearing a conformational p53 mutant.

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 8, p. 417, doi. 10.1007/s002620000137

By:

McArdle, Stephanie E. B.;
Rees, Robert C.;
Mulcahy, Kevin A.;
Saba, Jeanine;
McIntyre, Catherine A.;
Murray, Anna K.

Publication type:

Article

CD40 activation enhances the magnitude of cellular immune responses against p53 but not the avidity of the effectors.

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 8, p. 410, doi. 10.1007/s002620000135

By:

Erdile, Lorne F.;
Smith, Darlene

Publication type:

Article

Synergy between interleukin-2 and prothymosin α for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas.

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 8, p. 449, doi. 10.1007/s002620000132

By:

Voutsas, Ioannis F.;
Baxevanis, Constantin N.;
Gritzapis, Angelos D.;
Missitzis, Ioannis;
Stathopoulos, George P.;
Archodakis, George;
Banis, Constantin;
Voelter, Wolfgang;
Papamichail, Michael

Publication type:

Article

Inhibition of interleukin-10 (IL-10) production from MOPC 315 tumor cells by IL-10 antisense oligodeoxynucleotides enhances cell-mediated immune responses.

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 8, p. 433, doi. 10.1007/s002620000123

By:

Kim, Byung-Gyu;
Joo, Hong-Gu;
Chung, In-Sung;
Chung, Hee Yong;
Woo, Hee-Jong;
Yun, Yeon-Sook

Publication type:

Article